Exfoliative dermatitis - Exfoliative Dèrmatoz
☆ Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Red (burning) Skin Syndrome ― Eritem ak echèl sou tout kò a se sentòm prensipal Exfoliative Dèrmatoz (Exfoliative dermatitis).
References
Erythroderma se yon maladi po ki ra men grav. Pandan ke kòz egzak la souvan enkoni, li ka deklanche pa yon reyaksyon dwòg oswa yon kansè kache. Youn nan kansè komen ki lye ak dèrmatit èksfolyativ se lenfom T-selil kutane, ki ta ka pa montre sentòm pou mwa oswa menm ane apre kondisyon po a kòmanse. Anjeneral, entène lopital nesesè pou premye evalyasyon ak tretman. Pasyan ki gen maladi dwòg yo jeneralman gen yon bon pèspektiv alontèm, menm si ka san yon kòz klè yo gen tandans gen yon kou renouvlab ak remèt. Pwonostik la pou ka ki lye ak kansè anjeneral depann sou fason kansè nan pwogrese.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Li tipikman montre woujè toupatou ak ekaye ki kouvri plis pase 90% nan kò a. Kondisyon sa a se yon siy vizib nan divès pwoblèm sante kache tankou psoriasis, ekzema, oswa yon repons a sèten medikaman.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Kòz ki pi komen nan erythroderma se vin pi grav nan yon maladi po kache, tankou psoriasis, dèrmatoz kontak, dèrmatoz seboreik, lichen planus, pityriasis rubra pilaris oswa yon reyaksyon dwòg, tankou itilizasyon estewoyid aktualite. Manefestasyon prensipal la se mwens souvan epi anjeneral yo wè nan ka lenfom T-selil kutane. Paske li enpòtan pou diferansye li ak lenfom selil T kutane, yo fè yon byopsi.